CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Loading of CAR-T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism.
Loading of CAR-T cells with magnetic nanoparticles for controlled targeting suppresses inflammatory cytokine release and switches tumor cell death mechanism.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
嵌合抗原受体(CAR)T细胞治疗血液系统恶性肿瘤显示出很大潜力,但其治疗实体瘤的成功受到肿瘤运输和浸润有限、实体瘤癌症特异性抗原稀少等因素制约。
因此,在目标部位富集肿瘤抗原特异性CAR-T 细胞,对于提高疗效、降低全身性靶上非肿瘤毒性至关重要。本研究以超顺磁性氧化铁纳米颗粒(SPION)对人CAR-T 细胞进行功能化改造,使其可受磁场控制并实现部位靶向。负载SPION的CAR-T 细胞仍能特异性杀伤表达CAR靶抗原硫酸软骨素蛋白聚糖(CSPG4)的黑色素瘤细胞。
重要的是,SPION抑制了负载CAR-T 细胞的细胞因子释放,并使肿瘤细胞死亡表型由细胞焦亡转为细胞凋亡。此外,在动态流动模型中,负载SPION的CAR-T 细胞可通过外部磁场富集,并能够通过MRI检测。这些结果表明,SPION功能化后CAR-T 细胞仍保留裂解性细胞毒能力,为未来针对实体瘤、减少全身不良反应的部位特异性免疫疗法奠定了基础。
Therapies against hematological malignancies using chimeric antigen receptors (CAR)-T cells have shown great potential; however, therapeutic success in solid tumors has been constrained due to limited tumor trafficking and infiltration, as well as the scarcity of cancer-specific solid tumor antigens.
Therefore, the enrichment of tumor-antigen specific CAR-T cells in the desired region is critical for improving therapy efficacy and reducing systemic on-target/off-tumor side effects.
Here, we functionalized human CAR-T cells with superparamagnetic iron oxide nanoparticles (SPIONs), making them magnetically controllable for site-directed targeting. SPION-loaded CAR-T cells maintained their specific cytolytic capacity against melanoma cells expressing the CAR-specific antigen chondroitin sulfate proteoglycan (CSPG4).
Importantly, SPIONs suppressed cytokine release in the loaded CAR-T cells, shifting the cell death phenotype in the tumor cells from pyroptosis to apoptosis.
Furthermore, SPION-loaded CAR-T cells could be enriched in a dynamic flow model through an external magnetic field and be detected in MRI. These results demonstrate that lytic cytotoxicity is retained after SPION-functionalization and provides a basis for future site-specific immunotherapies against solid tumors with reduced systemic adverse side effects.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。